$0.94
-0.04(-3.70%)
Mkt Cap $11M
$0.40
$1.40
52-Week Range
At A Glance
1
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions.
2
No significant events in the past 90 days.
$11M
Market Cap
—
Revenue
—
Net Income
Employees5
Fundamentals
How The Business Makes Money
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Industry Biotechnology
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0001622667
ISINUS00791X2099
CUSIP00791X209
Phone949-354-6499
Address4040 Macarthur Boulevard, Newport Beach, CA, 92614, US
SEC EDGAR